Interface Inc TILE
We take great care to ensure that the data presented and summarized in this overview for INTERFACE INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding TILE
View all-
Black Rock Inc. New York, NY9.31MShares$247 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$156 Million0.0% of portfolio
-
Barrow Hanley Mewhinney & Strauss LLC Dallas, TX2.87MShares$76.3 Million0.19% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.64MShares$70 Million0.01% of portfolio
-
State Street Corp Boston, MA2.23MShares$59.3 Million0.0% of portfolio
-
Frontier Capital Management CO LLC2.2MShares$58.5 Million0.42% of portfolio
-
American Century Companies Inc Kansas City, MO1.77MShares$47.1 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA1.77MShares$47.1 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.48MShares$39.3 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.37MShares$36.4 Million0.0% of portfolio
Latest Institutional Activity in TILE
Top Purchases
Top Sells
About TILE
Interface, Inc., a modular flooring company, designs, produces, and sells modular carpet products primarily in the Americas, Europe, and the Asia-Pacific. The company offers modular carpets under the Interface and FLOR brand names; carpet tiles under the GlasBacRE name for use in commercial interiors, including offices, healthcare facilities, airports, educational and other institutions, hospitality spaces, and retail facilities, as well as residential interiors; modular resilient flooring products; rubber flooring under the norament and noraplan brand names; and luxury vinyl tile products. It also produces and sells an adapted version of its carpet tile for the healthcare facilities market; and two-meter roll goods that are structure-backed for use in education, healthcare, and government markets, as well as carpet replacement, installation, and maintenance services. In addition, the company sells and licenses a proprietary antimicrobial chemical compound under the Intersept name for use in interior finishes; sells TacTiles, a carpet tile installation system, as well as various adhesives and products; and provides turnkey project management services for global accounts and other customers through its InterfaceSERVICES business. It sells its products directly to end-users, as well as indirectly through independent contractors or distributors, and FLOR line of products through Internet sales and commercial sales force. The company has product showrooms or design studios in the United States, Canada, Mexico, England, France, Germany, Spain, the Netherlands, India, Australia, Norway, the United Arab Emirates, Russia, Singapore, Hong Kong, Thailand, China, and others. Interface, Inc. was incorporated in 1973 and is headquartered in Atlanta, Georgia.
Insider Transactions at TILE
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 21
2024
|
Bruce Andrew Hausmann VP & CFO |
SELL
Open market or private sale
|
Direct |
30,000
-15.12%
|
$750,000
$25.5 P/Share
|
Nov 05
2024
|
Stansfield Nigel Vice President |
SELL
Open market or private sale
|
Direct |
20,000
-12.17%
|
$480,000
$24.12 P/Share
|
Aug 23
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
20,000
-10.46%
|
$360,000
$18.07 P/Share
|
Aug 21
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
3,555
-1.83%
|
$60,435
$17.53 P/Share
|
Aug 19
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
3,170
-1.6%
|
$53,890
$17.54 P/Share
|
Aug 16
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
2,275
-1.14%
|
$38,675
$17.51 P/Share
|
Aug 13
2024
|
Bruce Andrew Hausmann VP & CFO |
SELL
Open market or private sale
|
Direct |
55,000
-10.86%
|
$935,000
$17.01 P/Share
|
Aug 08
2024
|
Stansfield Nigel Vice President |
SELL
Open market or private sale
|
Direct |
17,500
-9.62%
|
$280,000
$16.44 P/Share
|
Aug 05
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
3,403
-1.67%
|
$51,045
$15.99 P/Share
|
Aug 01
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
5,745
-2.74%
|
$97,665
$17.6 P/Share
|
Jul 26
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
2,952
-1.39%
|
$50,184
$17.64 P/Share
|
Jul 25
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
1,400
-0.66%
|
$23,800
$17.51 P/Share
|
Jul 23
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
17,300
-7.49%
|
$294,100
$17.05 P/Share
|
Jul 18
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
200
-0.09%
|
$3,400
$17.0 P/Share
|
Jul 16
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
15,000
-6.09%
|
$240,000
$16.56 P/Share
|
Jul 08
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
2,153
-0.87%
|
$30,142
$14.67 P/Share
|
Jul 05
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
10,347
-4.0%
|
$144,858
$14.43 P/Share
|
Jun 06
2024
|
Daniel T Hendrix |
SELL
Open market or private sale
|
Direct |
12,500
-4.61%
|
$187,500
$15.05 P/Share
|
May 13
2024
|
Catherine M Kilbane |
BUY
Grant, award, or other acquisition
|
Direct |
7,015
+10.37%
|
-
|
May 13
2024
|
Robert T O'Brien |
BUY
Grant, award, or other acquisition
|
Direct |
7,015
+18.92%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 411K shares |
---|
Payment of exercise price or tax liability | 242K shares |
---|---|
Open market or private sale | 242K shares |